keyword
https://read.qxmd.com/read/38703159/cost-effectiveness-of-medical-therapy-for-heart%C3%A2-failure-with-mildly-reduced-and-preserved-ejection-fraction
#1
JOURNAL ARTICLE
Neal M Dixit, Katie P Truong, Muthiah Vaduganathan, Boback Ziaeian, Gregg C Fonarow
BACKGROUND: Three medications are now guideline-recommended treatments for heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF), however, the cost-effectiveness of these agents in combination has yet to be established. OBJECTIVES: The purpose of this study was to determine the cost-effectiveness of mineralocorticoid receptor antagonists (MRA), angiotensin receptor-neprilysin inhibitors (ARNIs), and sodium glucose co-transporter 2 inhibitors (SGLT2is) in individuals with HFmrEF/HFpEF...
April 18, 2024: JACC. Heart Failure
https://read.qxmd.com/read/38692717/cost-analysis-for-initiating-an-integrated-package-of-essential-non-communicable-disease-interventions-pen-plus-in-kondoa-district-hospital-tanzania-a-time-driven-activity-based-costing-tdabc-study-protocol
#2
JOURNAL ARTICLE
Harrieth Peter Ndumwa, Amani Thomas Mori, George Mugambage Ruhago, Ritha Willilo, Ryan McBain, Chantelle Boudreaux, Emily Wroe, Alma J Adler, Gene Bukhman, Mary Theodory Mayige, Oddvar Kaarboe
INTRODUCTION: Non-communicable diseases (NCDs) constitute approximately 74% of global mortality, with 77% of these deaths occurring in low-income and middle-income countries. Tanzania exemplifies this situation, as the percentage of total disability-adjusted life years attributed to NCDs has doubled over the past 30 years, from 18% to 36%. To mitigate the escalating burden of severe NCDs, the Tanzanian government, in collaboration with local and international partners, seeks to extend the integrated package of essential interventions for severe NCDs (PEN-Plus) to district-level facilities, thereby improving accessibility...
May 1, 2024: BMJ Open
https://read.qxmd.com/read/38659615/missed-opportunity-to-diagnose-palliative-care-need-among-older-emergency-department-patients-in-a-middle-income-country-a-retrospective-study
#3
JOURNAL ARTICLE
Jiraporn Sri-On, Jesda Phumsrisawat, Rapeeporn Rojsaengroeng
PURPOSE: This study aimed to determine the percentage of missed opportunities (MOs) to identify and treat older adults presenting with palliative care (PC) needs at one emergency department (ED). The secondary objective was to determine the rate of treatment interventions regardless of whether the patients received a PC plan as well as the direct cost of treatment. PATIENTS AND METHODS: In this retrospective study, PC need was determined using broad and narrow criteria...
2024: Open Access Emergency Medicine: OAEM
https://read.qxmd.com/read/38634912/health-and-economic-impact-of-dapagliflozin-for-type-2-diabetes-patients-who-had-or-were-at-risk-for-atherosclerotic-cardiovascular-disease-in-the-italian-general-practitioners-setting-a-budget-impact-analysis
#4
JOURNAL ARTICLE
Paolo Angelo Cortesi, Ippazio Cosimo Antonazzo, Pasquale Palladino, Marco Gnesi, Silvia Mele, Marco D'Amelio, Elena Zanzottera Ferrari, Giampiero Mazzaglia, Lorenzo Giovanni Mantovani
AIM: In 2022, in Italy, general practitioners (GPs) have been allowed to prescribe SGLT2i in Type 2 Diabetes (T2D) under National Health Service (NHS) reimbursement. In the pivotal clinical trial named DECLARE-TIMI 58, dapagliflozin reduced the risk of hospitalization for heart failure, CV death and kidney disease progression compared to placebo in a population of T2D patients. This study evaluated the health and economic impact of dapagliflozin for T2D patients who had or were at risk for atherosclerotic cardiovascular disease in the Italian GPs setting...
April 18, 2024: Acta Diabetologica
https://read.qxmd.com/read/38630571/a-direct-digital-40-%C3%AE-a-100-kb-s-intracardiac-communication-receiver-with-250-%C3%AE-s-startup-time-for-low-duty-cycle-leadless-pacemaker-synchronization
#5
JOURNAL ARTICLE
Adrian Ryser, Christof Baeriswyl, Michel Moser, Jurgen Burger, Tobias Reichlin, Thomas Niederhauser, Andreas Haeberlin
The first commercial dual-chamber leadless pacemaker (LLPM) was introduced recently. The system combines two separate implants situated in the right atrium and the right ventricle of the heart. Implant synchronization is accomplished with conductive intracardiac communication (CIC) using the myocardium and blood as transmission channel. Successful implant synchronization of this dual-chamber LLPM has been demonstrated. However, the continuously active synchronization transceivers, consuming about 800 nA, cause a 25-45% reduction in the projected device longevity...
April 17, 2024: IEEE Transactions on Biomedical Circuits and Systems
https://read.qxmd.com/read/38610755/role-of-palliative-care-in-the-supportive-management-of-al-amyloidosis-a-review
#6
REVIEW
Muhammad Hamza Habib, Yun Kyoung Ryu Tiger, Danai Dima, Mathias Schlögl, Alexandra McDonald, Sandra Mazzoni, Jack Khouri, Louis Williams, Faiz Anwer, Shahzad Raza
Light chain amyloidosis is a plasma-cell disorder with a poor prognosis. It is a progressive condition, causing worsening pain, disability, and life-limiting complications involving multiple organ systems. The medical regimen can be complex, including chemotherapy or immunotherapy for the disease itself, as well as treatment for pain, gastrointestinal and cardiorespiratory symptoms, and various secondary symptoms. Patients and their families must have a realistic awareness of the illness and of the goals and limitations of treatments in making informed decisions about medical therapy, supportive management, and end-of-life planning...
March 29, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38583185/telephone-based-guideline-directed-medical-therapy-optimization-in-navajo-nation-the-h%C3%A3-zh%C3%A3-randomized-clinical-trial
#7
JOURNAL ARTICLE
Lauren A Eberly, Ada Tennison, Daniel Mays, Chih-Yuan Hsu, Chih-Ting Yang, Ernest Benally, Harriett Beyuka, Benjamin Feliciano, C Jane Norman, Maria Ynes Brueckner, Clybert Bowannie, Daniel R Schwartz, Erica Lindsey, Stephen Friedman, Elizabeth Ketner, Pamela Detsoi-Smiley, Yu Shyr, Sonya Shin, Maricruz Merino
IMPORTANCE: Underutilization of guideline-directed medical therapy for heart failure with reduced ejection fraction is a major cause of poor outcomes. For many American Indian patients receiving care through the Indian Health Service, access to care, especially cardiology care, is limited, contributing to poor uptake of recommended therapy. OBJECTIVE: To examine whether a telehealth model in which guideline-directed medical therapy is initiated and titrated over the phone with remote telemonitoring using a home blood pressure cuff improves guideline-directed medical therapy use (eg, drug classes and dosage) in patients with heart failure with reduced ejection fraction in Navajo Nation...
April 7, 2024: JAMA Internal Medicine
https://read.qxmd.com/read/38583107/trends-in-oral-anticoagulant-use-and-individual-expenditures-across-the-united-states-from-2014-to-2020
#8
JOURNAL ARTICLE
Omar S Alkhezi, Leo F Buckley, John Fanikos
BACKGROUND: Landmark clinical trials have expended the indications for the direct oral anticoagulants (DOACs), but contemporary data on usage and expenditure patterns are lacking. OBJECTIVE: This study aimed to assess annual trends in oral anticoagulant (OAC) utilization and expenditure across the United States (US) from 2014 to 2020. METHODS: We utilized the Medical Expenditure Panel Survey (MEPS) to study the trends of use and expenditures of warfarin, dabigatran, rivaroxaban, apixaban, and edoxaban between 2014 and 2020 in the US...
April 7, 2024: American Journal of Cardiovascular Drugs: Drugs, Devices, and Other Interventions
https://read.qxmd.com/read/38543326/polymer-drug-anti-thrombogenic-and-hemocompatible-coatings-as-surface-modifications
#9
REVIEW
Barbara Zawidlak-Węgrzyńska, Joanna Rydz, Marta Musioł, Aneta Radziwon-Balicka
Since the 1960s, efforts have been made to develop new technologies to eliminate the risk of thrombosis in medical devices that come into contact with blood. Preventing thrombosis resulting from the contact of a medical device, such as an implant, with blood is a challenge due to the high mortality rate of patients and the high cost of medical care. To this end, various types of biomaterials coated with polymer-drug layers are being designed to reduce their thrombogenicity and improve their hemocompatibility...
March 21, 2024: Pharmaceutics
https://read.qxmd.com/read/38533994/mobile-phone-text-messaging-for-medication-adherence-in-secondary-prevention-of-cardiovascular-disease
#10
REVIEW
Julie Redfern, Qiang Tu, Karice Hyun, Matthew A Hollings, Nashid Hafiz, Clara Zwack, Caroline Free, Pablo Perel, Clara K Chow
BACKGROUND: Cardiovascular diseases (CVDs) are the leading cause of death globally, accounting for almost 18 million deaths annually. People with CVDs have a five times greater chance of suffering a recurrent cardiovascular event than people without known CVDs. Although drug interventions have been shown to be cost-effective in reducing the risk of recurrent cardiovascular events, adherence to medication remains suboptimal. As a scalable and cost-effective approach, mobile phone text messaging presents an opportunity to convey health information, deliver electronic reminders, and encourage behaviour change...
March 27, 2024: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/38532921/determining-the-role-of-nt-probnp-levels-in-diabetic-patients-with-heart-failure-a-study-from-north-india
#11
JOURNAL ARTICLE
Merajul H Siddiqui, Ritvija Dixit, Shikha Agarwal, Subhash Chandra Jha, Harshita Khanna, Sonu Kumari Agrawal
BACKGROUND: Diabetic patients are at higher risk of cardiovascular morbidity and mortality. NT-proBNP levels measurements are useful for the assessment of risk in heart failure patients in emergency condition and give the faster result. Further, it also offers lower cost and unnecessary hospitalization and follow-up cost. The studies have shown that NT-proBNP levels are a direct predictor of outcome risk in diabetic patients with heart failure. The objective of this research was to study the role of NT-proBNP levels to determine the severity of heart failure in diabetic patients...
2024: Journal of Education and Health Promotion
https://read.qxmd.com/read/38528616/clinical-and-economic-burden-of-respiratory-syncytial-virus-in-children-aged-0-5-years-in-italy
#12
JOURNAL ARTICLE
Melania Dovizio, Chiara Veronesi, Fausto Bartolini, Arturo Cavaliere, Stefano Grego, Romina Pagliaro, Cataldo Procacci, Loredana Ubertazzo, Lorenzo Bertizzolo, Barbara Muzii, Salvatore Parisi, Valentina Perrone, Eugenio Baraldi, Elena Bozzola, Fabio Mosca, Luca Degli Esposti
BACKGROUND: Respiratory syncytial virus (RSV) is among the leading causes of hospitalization due to lower respiratory tract infections (LRTIs) in children younger than 5 years worldwide and the second cause of infant death after malaria. RSV infection occurs in almost all the infants before the second year of life with variable clinical severity, often requiring medical assistance. This analysis investigated patients aged 0-5 years with RSV infection focusing on epidemiology, clinical features, and economic burden of RSV-associated hospitalizations in a setting of Italian real clinical practice...
March 25, 2024: Italian Journal of Pediatrics
https://read.qxmd.com/read/38517666/costs-attributable-to-hypercholesterolemia-in-a-single-period-and-over-the-life-cycle
#13
JOURNAL ARTICLE
Stephanie Reitzinger, Miriam Reiss, Thomas Czypionka
Hypercholesterolemia is a major risk factor for atherosclerotic cardiovascular disease leading to reduced (healthy) life years. The aim of this study is to quantify the societal costs associated with hypercholesterolemia. We use epidemiologic data on the distribution of cholesterol levels as well as data on relative risks regarding ischemic heart disease, stroke, and other cardiovascular diseases. The analytical approach is based on the use of population-attributable fractions applied to direct medical, direct non-medical and indirect costs using data of Austria...
March 22, 2024: European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care
https://read.qxmd.com/read/38515335/long-term-cost-effectiveness-of-transcatheter-mitral-valve-repair-in-%C3%A2-hf-patients-with-secondary-mitral-regurgitation
#14
JOURNAL ARTICLE
Younan Yao, Ziyou Zhou, Tian Geng, Anping Cai, Tian Li, Junqing Yang, Jiyan Chen, Liwen Li
AIMS: The long-term cost-effectiveness of MitraClip in heart failure patients with secondary mitral regurgitation is still unclear. This study aimed to evaluate the long-term cost-effectiveness of MitraClip added to guideline-directed medical therapy vs. guideline-directed medical therapy alone in heart failure patients with secondary mitral regurgitation from the perspective of the healthcare systems of mainland China, the United Kingdom, Germany, and the United States. METHODS AND RESULTS: A two-stage (decision + Markov) model was built...
March 22, 2024: ESC Heart Failure
https://read.qxmd.com/read/38509576/a-cluster-randomized-study-to-evaluate-the-effectiveness-and-cost-effectiveness-of-the-assessment-of-burden-of-chronic-conditions-abcc-tool-in-south-tyrolean-primary-care-for-patients-with-copd-asthma-type-2-diabetes-and-heart-failure-the-abcc-south-tyrol-study
#15
JOURNAL ARTICLE
Christian J Wiedermann, Pasqualina Marino, Angelika Mahlknecht, Verena Barbieri, Giuliano Piccoliori, Adolf Engl, Annerika H M Gidding-Slok
BACKGROUND: Chronic diseases, such as chronic obstructive pulmonary disease (COPD), asthma, type 2 diabetes, and heart failure, often coexist and contribute to a significant burden on individuals and health systems. The Assessment of Burden of Chronic Conditions (ABCC) tool, already in routine clinical use in the Netherlands, aims to comprehensively assess and visualize disease burden, stimulate self-management, and encourage shared decision-making. This study aims to validate the German and Italian versions of the ABCC tool and evaluate its effectiveness and cost-effectiveness in the South Tyrolean Primary Care setting...
March 20, 2024: Trials
https://read.qxmd.com/read/38498242/community-preferences-for-the-care-of-older-people-at-the-end-of-life-how-important-is-the-disease-context
#16
JOURNAL ARTICLE
Patricia Kenny, Deborah J Street, Jane Hall, Meera R Agar, Jane Phillips
BACKGROUND: Population preferences for care at the end of life can inform palliative care policy and direction. Research investigating preferences for care at the end of life has focused predominantly on the context of advanced cancer, with relatively little attention to other life-limiting illnesses that are common causes of death. OBJECTIVES: We aimed to investigate preferences for the care of older people at the end of life in three different disease contexts...
March 18, 2024: Patient
https://read.qxmd.com/read/38488779/health-and-economic-value-of-eliminating-socioeconomic-disparities-in-us-youth-physical-activity
#17
JOURNAL ARTICLE
Tiffany M Powell-Wiley, Marie F Martinez, Jessie Heneghan, Colleen Weatherwax, Foster Osei Baah, Kavya Velmurugan, Kevin L Chin, Colby Ayers, Manuel A Cintron, Lola R Ortiz-Whittingham, Dana Sandler, Sonal Sharda, Meredith Whitley, Sarah M Bartsch, Kelly J O'Shea, Alexandra Tsintsifas, Alexis Dibbs, Sheryl A Scannell, Bruce Y Lee
IMPORTANCE: There are considerable socioeconomic status (SES) disparities in youth physical activity (PA) levels. For example, studies show that lower-SES youth are less active, have lower participation in organized sports and physical education classes, and have more limited access to PA equipment. OBJECTIVE: To determine the potential public health and economic effects of eliminating disparities in PA levels among US youth SES groups. DESIGN AND SETTING: An agent-based model representing all 6- to 17-year-old children in the US was used to simulate the epidemiological, clinical, and economic effects of disparities in PA levels among different SES groups and the effect of reducing these disparities...
March 1, 2024: JAMA health forum
https://read.qxmd.com/read/38476807/advancements-in-heart-transplantation-donor-derived-cell-free-dna-as-next-generation-biomarker
#18
REVIEW
Pawel Borkowski, Nikita Singh, Natalia Borkowska
Heart failure, particularly in its advanced stages, significantly impacts quality of life. Despite progress in Guideline-Directed Medical Therapy (GDMT) and invasive treatments, heart transplantation (HT) remains the primary option for severe cases. However, complications such as graft rejection present significant challenges that necessitate effective monitoring. Endomyocardial biopsy (EMB) is the gold standard for detecting rejection, but its invasive nature, associated risks, and healthcare costs have shifted interest in non-invasive techniques...
February 2024: Curēus
https://read.qxmd.com/read/38476579/the-economic-impact-of-obesity-in-turkey-a-micro-costing-analysis
#19
JOURNAL ARTICLE
Dilek Gogas Yavuz, Omar Akhtar, Kaywei Low, Adrien Gras, Batu Gurser, Esra Safak Yilmaz, Amaury Basse
BACKGROUND: Turkey currently has the highest obesity prevalence among its European counterparts. 32% and 61% of the population live with obesity and overweight, respectively. Overweight and obesity are linked to non-communicable diseases that incur incremental health and economic costs. The significant public health concern warrants an assessment of the cost of obesity. METHODS: A micro-costing approach from the public payer perspective was conducted to estimate direct healthcare costs associated with ten obesity-related comorbidities (ORCs) in Turkey...
2024: ClinicoEconomics and Outcomes Research: CEOR
https://read.qxmd.com/read/38365072/out-of-pocket-prescription-drug-costs-for-adults-with-cardiovascular-risk-factors-under-amazon-s-direct-to-consumer-pharmacy-service
#20
JOURNAL ARTICLE
D August Oddleifson, Zhaonian Zheng, Rishi K Wadhera
BACKGROUND: US adults often overpay for generic prescription medications, which can lead to medication nonadherence that negatively impacts cardiovascular outcomes. As a result, new direct-to-consumer online medication services are growing in popularity nationwide. Amazon recently launched a $5/month direct-to-consumer medication subscription service (Amazon RxPass), but it is unclear how many US adults could save on out-of-pocket drug costs by using this new service. OBJECTIVES: To estimate out-of-pocket savings on generic prescription medications achievable through Amazon's new direct-to-consumer subscription medication service for adults with cardiovascular risk factors and/or conditions...
February 14, 2024: American Heart Journal
keyword
keyword
41681
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.